Global Wearable Cardiac Devices Market by Product Type (Wearable ECG Monitors, Wearable Heart Rate Monitors, Wearable Blood Pressure Monitors, Wearable Holter Monitors), by End-Use Industry (Healthcare Providers, Pharmaceutical Companies, Fitness and Wellness Providers, Research Institutes), by Application (Arrhythmia Detection and Monitoring, Cardiac Rehabilitation, Chronic Disease Management, Fitness and Performance Tracking); Insights & Forecast (2024 - 2030) and By Region; Global Insights & Forecast (2023 - 2030)

As per Intent Market Research, the Wearable Cardiac Devices Market was valued at USD 6.7 billion in 2024-e and will surpass USD 17.5 billion by 2030; growing at a CAGR of XX% during 2025 - 2030.

The wearable cardiac devices market is experiencing rapid growth as more individuals and healthcare providers adopt portable technologies for the continuous monitoring and management of heart-related conditions. These devices provide real-time data on critical cardiovascular parameters, enabling early detection of arrhythmias, heart disease, and other cardiovascular abnormalities. With the rising prevalence of cardiovascular diseases, there is an increasing demand for wearable devices that facilitate proactive health management. This market is driven by innovations in sensor technologies, improvements in wireless connectivity, and an increasing consumer demand for personalized, remote healthcare solutions.

Wearable cardiac devices offer the advantage of continuous, non-invasive monitoring, which empowers individuals to track their heart health independently and take timely action if necessary. Additionally, these devices are becoming integral to the clinical setting, as they provide healthcare providers with valuable insights into patient conditions, enabling better treatment outcomes. As the wearable technology ecosystem continues to evolve, there are expanding opportunities in both consumer health and clinical applications, positioning the wearable cardiac devices market for strong future growth.

Wearable ECG Monitors Segment is Largest Owing to Growing Demand for Arrhythmia Detection

The wearable ECG monitors segment is the largest in the wearable cardiac devices market, driven by the growing demand for real-time arrhythmia detection and the continuous monitoring of heart health. Electrocardiogram (ECG) monitors are widely used for detecting and diagnosing irregular heart rhythms, which are increasingly prevalent among individuals with cardiovascular disease or those at risk. Wearable ECG monitors provide a convenient, non-invasive solution that allows for continuous monitoring of heart activity, offering both patients and healthcare providers a way to track arrhythmia events in real-time. This segment has seen rapid adoption, particularly among people with a history of heart disease or those predisposed to conditions such as atrial fibrillation.

The increasing prevalence of cardiovascular diseases, as well as the aging global population, has contributed to the demand for more accessible and effective methods of heart disease management. Wearable ECG monitors allow for early detection of potentially life-threatening arrhythmias, ensuring that timely medical interventions can be made to prevent more severe health events. Their ability to offer continuous, remote monitoring makes them an essential tool in modern healthcare, helping patients manage their condition outside of clinical environments, which is fueling the growth of this segment.

Wearable Blood Pressure Monitors Segment is Fastest Growing Owing to Rising Hypertension Prevalence

The wearable blood pressure monitors segment is the fastest growing in the wearable cardiac devices market, driven by the increasing global prevalence of hypertension and the growing demand for devices that enable continuous monitoring of blood pressure. High blood pressure is a major risk factor for heart disease and stroke, making its management critical for maintaining cardiovascular health. Wearable blood pressure monitors provide a convenient and accurate way for individuals to track their blood pressure levels throughout the day, ensuring better disease management and early detection of potential health issues.

With a shift towards home-based care and self-monitoring, wearable blood pressure monitors have become essential for people with hypertension, enabling them to keep track of their health without frequent visits to healthcare facilities. Additionally, the integration of these devices with smartphone apps allows for real-time monitoring and data sharing with healthcare providers, making it easier to adjust treatment plans and manage the condition more effectively. As the demand for proactive healthcare solutions increases, wearable blood pressure monitors are expected to see rapid growth in the coming years.

Cardiac Rehabilitation Application is Largest Owing to the Increasing Focus on Post-Surgery Recovery

The cardiac rehabilitation application segment is the largest within the wearable cardiac devices market, driven by the increasing number of individuals recovering from heart surgeries and cardiovascular events. Cardiac rehabilitation is a medically supervised program designed to improve the cardiovascular health of patients after events such as heart attacks, bypass surgeries, or stent placements. Wearable cardiac devices play a critical role in cardiac rehabilitation by allowing continuous monitoring of patients’ vital signs, including heart rate and ECG data, ensuring that patients are recovering safely and at an optimal pace.

These devices provide valuable insights into the effectiveness of rehabilitation programs, helping healthcare providers adjust treatment protocols based on real-time data. By offering constant monitoring, wearable devices enhance patient adherence to rehabilitation programs and reduce the need for frequent hospital visits, making the recovery process more convenient and efficient. The increasing focus on reducing hospital readmissions and improving patient outcomes is expected to further fuel the growth of the cardiac rehabilitation segment, establishing it as the largest application in the market.

Healthcare Providers Segment is Largest End-Use Industry Owing to Rising Adoption of Remote Monitoring Solutions

The healthcare providers segment is the largest end-use industry in the wearable cardiac devices market, driven by the growing adoption of remote patient monitoring (RPM) and telemedicine solutions in healthcare settings. Healthcare providers, including hospitals and clinics, are increasingly using wearable cardiac devices to monitor patients’ cardiovascular health in real-time, offering a more personalized and proactive approach to treatment. These devices enable healthcare providers to track patients remotely, allowing for early detection of any issues that may require intervention.

The integration of wearable cardiac devices into clinical practices helps improve patient outcomes by providing continuous data, which can inform clinical decisions and adjustments to treatment plans. The ability to monitor patients at home or in outpatient settings reduces the burden on healthcare facilities and supports the shift toward more patient-centered, home-based care. With healthcare providers seeking to improve care efficiency and patient outcomes while reducing costs, the wearable cardiac devices market is expected to continue to see strong growth within this segment.

North America is Largest Region Owing to Advanced Healthcare Infrastructure and High Adoption Rates

North America is the largest region in the wearable cardiac devices market, driven by the region’s advanced healthcare infrastructure, high adoption rates of wearable health technology, and rising awareness about cardiovascular diseases. The United States, in particular, has a well-established healthcare system that is increasingly incorporating wearable technologies to enhance patient care. The demand for wearable cardiac devices in North America is also fueled by the high prevalence of cardiovascular diseases and the need for continuous monitoring and early detection.

In addition to the high rate of adoption among healthcare providers, North American consumers are increasingly using wearable cardiac devices for fitness and wellness purposes, contributing to the growth of the market. The presence of leading market players, along with a favorable regulatory environment and ongoing healthcare reforms, ensures that North America will continue to dominate the wearable cardiac devices market in the foreseeable future.

Competitive Landscape

The wearable cardiac devices market is competitive, with a diverse range of companies vying for market share. Key players include Apple, Fitbit, Garmin, Medtronic, and Philips, among others. These companies are focusing on innovation, with an emphasis on improving device accuracy, expanding functionality, and enhancing user experience. Strategic partnerships and collaborations with healthcare providers and technology companies are also common as companies aim to integrate their devices into broader healthcare ecosystems.

The market is expected to remain competitive as technological advancements continue to drive innovation. Companies are increasingly incorporating advanced features, such as wireless connectivity, artificial intelligence, and machine learning, to enhance the functionality and value of their devices. As wearable cardiac devices become more integrated into telemedicine and remote patient monitoring platforms, competition will intensify, with new entrants bringing fresh innovations to the market.

Recent Developments:

• Abbott Laboratories launched the latest version of its wearable heart monitor, designed for patients with arrhythmias, offering enhanced data accuracy and ease of use.
• Medtronic PLC received FDA approval for its next-generation wearable ECG device, which offers real-time monitoring and automated alerts for cardiac events.
• Biotronik SE & Co. KG introduced a new wearable cardiac monitoring patch that integrates seamlessly with mobile health platforms to provide continuous heart data.
• Fitbit, Inc. expanded its wearable cardiac device offerings with a new wristband that tracks heart rate variability, ECG, and physical activity.
• AliveCor announced a partnership with a leading health insurer to integrate its KardiaMobile ECG device into patient care plans for better monitoring of cardiac conditions.

List of Leading Companies:

• Abbott Laboratories
• Medtronic PLC
• Boston Scientific Corporation
• Philips Healthcare
• Fitbit, Inc.
• Dexcom, Inc.
• Biotronik SE & Co. KG
• iRhythm Technologies, Inc.
• Withings
• AliveCor
• Garmin Ltd.
• Honeywell Life Care Solutions
• CardioComm Solutions, Inc.
• Omron Healthcare, Inc.
• Qardio, Inc.

Report Scope: